← All trials
NCT05036278
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 22, 2021
- Primary completion
- Jan 23, 2023
- Completion date
- Jan 23, 2023
- First posted
- Sep 5, 2021
- Last posted
- Nov 3, 2021
- Enrollment
- 70
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- BayerLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.